ARTICLES BY THIS AUTHOR
- 8/6/2013
HMMS adopts GS1 standards to improve supply chain operations
LONDON, Ont. | Healthcare Materials Management Services says it's taking a step forward in supply chain optimization with its adoption of GS1 standards and services to enhance its integrated purchasing, accounts payable and inventory management services. - 8/6/2013
Thiessen releases report on cancer drug supply chain
Pharmacist charged with reviewing Ontario’s chemotherapy under-dosing crisis unveils his findings - 8/6/2013
First International Forum on Health set for October in Montreal
MONTREAL | Forum Santé International 2013, the first International Forum on Health will be held in Montreal Oct. 22-24. The forum is being organized by the five University Health Centres of Quebec (Conférence des CHU du Québec) in co-operation with partners of the healthcare system and the Palais des Congrès de Montréal. - 8/6/2013
College probes MD who allegedly misrepresented professional credential
A cardiologist in Windsor, Ont., is facing a disciplinary hearing on allegations he misrepresented a professional credential and that he failed to provide "accurate and comprehensive information." - 8/5/2013
Press Review - August 6, 2013
Check out our review of recent healthcare stories in the media - <strong>Top Story: </strong>Squandering billions on health care. Read this and more. - 8/5/2013
NPs not solution to ER wait times, doctor says
The chief of emergency medicine at Eastern Health says putting more nurse practitioners in hospitals won't help reduce the wait times patients are dealing with. - 8/5/2013
CMA awards Medal of Service to Dr. Léo-Paul Landry
Quebec physician Dr. Léo-Paul Landry will get a special honour from the Canadian Medical Association thanks to his work to advance Canadian health care. - 8/5/2013
Book of the Month Q&A: The Truth About Statins
In her eye opening book, cardiologist Dr. Barbara Brown explains why she feels statins aren't the miracle cures they're purported to be. In making her case, she paints a picture of an “unholy, very lucrative” alliance between drug companies, the FDA and health professionals.